Skip to content
PeptideRank
Claya logo

Provider review

Claya cost: $299/mo semaglutide

Its renewal price appears on one page — an orphaned copy of an old homepage.

Compounded semaglutide renews at $299 and tirzepatide at $399, but $299 appears only on an archived homepage nobody links to and $399 appears nowhere on the site at all.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

1 of 4 disclosed openly

What Claya discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit Claya

Pharmacy

Not categorized

Labs

Not published as a requirement, cost or cadence.

States

Not published

On this page

What it actually costs

$299/moSemaglutide, per month

What this price covers

Medication

Included

Provider visits

Not confirmed

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not disclosed

The catch — The advertised $179 is a first month that renews at $299, and the $149 is a 12-month $1,788 prepay. Its own strike-through anchor of $279 does not match its real $299 standing rate, so even the comparison figure is wrong.

See plans at Claya

Prices read from Claya's own site · August 2026

What they advertise

Advertised "as low as $149/mo" semaglutide and "from $199/mo" tirzepatide on the homepage; "As low as $179/month" on the product pages; a "$279" strike-through anchor on one page. Sermorelin "as low as $199/mo," NAD+ "$199/mo," TRT "$179/mo," and brand-name pens at $1,299-$1,399.

What you actually pay

$299/mo compounded semaglutide and $399/mo compounded tirzepatide — the renewal rates its own subscription API returns.

Money you will meet later

  • The 12-month plans are charged in full upfront: $1,788 semaglutide and $2,388 tirzepatide.

The bottom line

Claya sells compounded semaglutide at a standing $299/month and compounded tirzepatide at $399/month, both confirmed from its own subscription API. Almost none of that reaches the site. The homepage advertises "as low as $149/mo," which is a 12-month $1,788 prepay; product pages say "as low as $179/month," which is a first month renewing at $299; one page carries a $279 strike-through anchor that matches neither. The only place $299 is printed is an orphaned archived homepage, and $399 — the tirzepatide renewal rate — appears nowhere on claya.com at all. It also markets sermorelin, NAD+ and TRT at "as low as" prices with no purchasable plan behind them.

Claya appears on our semaglutide provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You are prepaying twelve months anyway — the $1,788 and $2,388 annual totals are real, and its ladder totals reconcile.
  • You want the ladder totals to hold up: its $1,788 and $2,388 annual charges match its own per-month figures.

Look elsewhere if

  • You want to know what you will be charged in month two: $299 appears only on an orphaned old homepage and $399 appears nowhere.
  • You are shopping its sermorelin, NAD+ or TRT pages — all carry "as low as" prices with no purchasable plan behind them.
  • You compare against its $279 strike-through anchor, which matches neither its own standing rate nor any plan it sells.

What Claya offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

No category stated

Claya does not name the pharmacy that fills your prescription.

What its own site says

Not named on anywhere on its site, and no 503A or 503B category is stated.

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Not published

Not published as a list.

The honest cons

The part they would rather you skipped

The price Claya will actually charge you in month two is published on exactly one page of its website, and that page is an orphaned copy of an old homepage that nothing links to. Compounded semaglutide renews at $299 — a figure that appears nowhere in the live navigation, the product pages or the pricing cards, only on the archived homepage. Compounded tirzepatide renews at $399, and that number appears nowhere on claya.com at all; it exists only inside the checkout funnel's JavaScript and the subscription API's response. Everything the reader is shown is something else: "as low as $149" is a 12-month $1,788 prepay, "as low as $179" is a first month, and the "$279" strike-through anchor used to make $179 look like a discount does not match Claya's own standing rate either.

  • Its $299 semaglutide renewal price appears only on an orphaned archived homepage — see this review's knock.
  • Its $399 tirzepatide renewal price appears nowhere on the public site at all.
  • The advertised "$179/month" is a first month that renews at $299.
  • Its "$279" strike-through anchor matches neither its own standing rate nor any plan it sells.
  • Sermorelin, NAD+ and TRT are marketed with "as low as" prices and no purchasable plan behind them.
  • No pharmacy is named and no state list is published.

None of this is unique to Claya — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all. The evidence below is where that gets settled.

Ready to get started?

Prices and plans in this category change often — check Claya's current pricing before you decide. Ours was read from their own site in August 2026.

See Claya pricing

Facts on this page reflect Claya's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Claya's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved. See our disclosure and editorial policy.

Claya

$299/mo · Semaglutide

Visit Claya